Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
2.860
-0.050 (-1.72%)
At close: Apr 28, 2026, 4:00 PM EDT
2.850
-0.010 (-0.34%)
After-hours: Apr 28, 2026, 5:33 PM EDT
Cabaletta Bio Employees
As of December 31, 2025, Cabaletta Bio had 156 total employees, including 154 full-time and 2 part-time employees. The number of employees decreased by 8 or -4.88% compared to the previous year.
Employees
156
Change (1Y)
-8
Growth (1Y)
-4.88%
Revenue / Employee
n/a
Profits / Employee
-$1,076,000
Market Cap
318.38M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 288 |
| Nautilus Biotechnology | 130 |
| Foghorn Therapeutics | 106 |
| Rezolute | 75 |
| Surrozen | 44 |
| Inhibikase Therapeutics | 35 |
| DiaMedica Therapeutics | 35 |
| Ovid Therapeutics | 23 |
CABA News
- 9 hours ago - Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel - GlobeNewsWire
- 9 hours ago - Cellares and Cabaletta Bio Sign 10-Year Commercial Supply Agreement to Scale Rese-cel - Business Wire
- 1 day ago - Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting - GlobeNewsWire
- 14 days ago - First Patients Dosed with Cabaletta Bio's Rese-cel Manufactured on Cellares' Automated Cell Shuttle™ Platform - Business Wire
- 5 weeks ago - Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Cabaletta Bio Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 2 months ago - Cabaletta Bio Transcript: Guggenheim Securities Emerging Outlook: Biotech Summit 2026 - Transcripts